Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$3.04 - $5.5 $6,499 - $11,759
2,138 Added 3.18%
69,400 $301,000
Q1 2023

May 15, 2023

SELL
$3.26 - $4.0 $3,628 - $4,452
-1,113 Reduced 1.63%
67,262 $241,000
Q4 2022

Feb 14, 2023

SELL
$3.63 - $4.03 $144,016 - $159,886
-39,674 Reduced 36.72%
68,375 $254,000
Q3 2022

Nov 14, 2022

SELL
$3.48 - $4.51 $22,007 - $28,521
-6,324 Reduced 5.53%
108,049 $405,000
Q2 2022

Aug 15, 2022

SELL
$3.82 - $4.89 $56,818 - $72,733
-14,874 Reduced 11.51%
114,373 $498,000
Q1 2022

May 16, 2022

SELL
$4.74 - $6.68 $97,132 - $136,886
-20,492 Reduced 13.69%
129,247 $615,000
Q4 2021

Feb 14, 2022

BUY
$6.15 - $7.68 $91,659 - $114,462
14,904 Added 11.05%
149,739 $946,000
Q3 2021

Nov 15, 2021

SELL
$6.5 - $8.38 $746,031 - $961,806
-114,774 Reduced 45.98%
134,835 $913,000
Q2 2021

Aug 16, 2021

BUY
$6.9 - $9.59 $1.72 Million - $2.39 Million
249,609 New
249,609 $1.84 Million
Q1 2021

May 17, 2021

SELL
$8.58 - $10.21 $147,361 - $175,356
-17,175 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$9.32 - $13.4 $5,163 - $7,423
554 Added 3.33%
17,175 $160,000
Q3 2020

Nov 16, 2020

SELL
$12.07 - $15.31 $495,473 - $628,475
-41,050 Reduced 71.18%
16,621 $201,000
Q2 2020

Aug 14, 2020

BUY
$10.25 - $16.54 $591,127 - $953,878
57,671 New
57,671 $780,000
Q3 2019

Nov 14, 2019

SELL
$10.8 - $14.6 $118,227 - $159,826
-10,947 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$10.68 - $14.55 $559,920 - $762,812
-52,427 Reduced 82.73%
10,947 $142,000
Q2 2019

Aug 14, 2019

SELL
$10.68 - $14.55 $1.25 Million - $1.7 Million
-116,629 Reduced 64.79%
63,374 $1.18 Million
Q1 2019

May 14, 2019

BUY
$12.54 - $16.12 $2.26 Million - $2.9 Million
180,003 New
180,003 $2.57 Million
Q4 2018

Feb 14, 2019

SELL
$10.06 - $14.87 $1.06 Million - $1.56 Million
-105,046 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$6.33 - $13.02 $12,805 - $26,339
-2,023 Reduced 1.89%
105,046 $1.15 Million
Q2 2018

Aug 14, 2018

BUY
$3.35 - $6.42 $29,359 - $56,264
8,764 Added 8.92%
107,069 $682,000
Q1 2018

May 15, 2018

SELL
$3.61 - $4.91 $47,034 - $63,972
-13,029 Reduced 11.7%
98,305 $355,000
Q4 2017

Feb 14, 2018

SELL
$4.43 - $6.43 $216,059 - $313,603
-48,772 Reduced 30.46%
111,334 $530,000
Q3 2017

Nov 14, 2017

BUY
$2.92 - $5.02 $467,509 - $803,732
160,106
160,106 $676,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $220M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.